Usefulness of alternate prognostic serum and plasma markers for antiretroviral therapy for human immunodeficiency virus type 1 infection.

@article{Kannangai2008UsefulnessOA,
  title={Usefulness of alternate prognostic serum and plasma markers for antiretroviral therapy for human immunodeficiency virus type 1 infection.},
  author={Rajesh Kannangai and Abraham J. Kandathil and David Lenin Ebenezer and Elezabeth Mathai and Agarwal Jai Prakash and Oriapadickal Cherian Abraham and Thambu David Sudarsanam and Susanne Alexander Pulimood and R. Selvakumar and Victoria Job and Gopalan Sridharan},
  journal={Clinical and vaccine immunology : CVI},
  year={2008},
  volume={15 1},
  pages={154-8}
}
In developing countries, the usability of peripheral blood constituents that are low-cost alternatives to CD4-positive (CD4+) T-cell and human immunodeficiency virus type 1 (HIV-1) RNA estimation should be evaluated as prognostic markers. The aim of our study was to investigate the use of plasma levels of dehydroepiandrosterone sulfate (DHEAS), albumin, and C-reactive protein (CRP) as alternate prognostic markers for antiretroviral treatment (ART) response in place of HIV-1 load measurements… CONTINUE READING